GALVANI BIOELECTRONICS Trademark

Trademark Overview


On Monday, February 27, 2017, a trademark application was filed for GALVANI BIOELECTRONICS with the United States Patent and Trademark Office. The USPTO has given the GALVANI BIOELECTRONICS trademark a serial number of 87350899. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Thursday, November 30, 2023. This trademark is owned by Glaxo Group Limited. The GALVANI BIOELECTRONICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development services in the fields of bioelectronics, [ drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biochemicals, ] biotechnology, [ biological products, ] medical apparatus, devices and instruments; development of new technology in the fields of bioelectronics; [ conducting clinical trials for others; scientific consulting in the field of medical research and medical technology; supply of information in the area of laboratory technology; medical laboratory services; ] provision of scientific information via Internet portals in the field of medical research and biotechnology
galvani bioelectronics

General Information


Serial Number87350899
Word MarkGALVANI BIOELECTRONICS
Filing DateMonday, February 27, 2017
Status701 - SECTION 8 - ACCEPTED
Status DateThursday, November 30, 2023
Registration Number5276488
Registration DateTuesday, August 29, 2017
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, June 13, 2017

Trademark Statements


Description of MarkThe mark consists of the wording "GALVANI BIOELECTRONICS" in stylized form, the word "BIOELECTRONICS" appears in smaller capital block letters below "GALVANI" and between the middle of the first letter "A" and "I" in "GALVANI".
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"BIOELECTRONICS"
Goods and ServicesResearch and development services in the fields of bioelectronics, [ drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biochemicals, ] biotechnology, [ biological products, ] medical apparatus, devices and instruments; development of new technology in the fields of bioelectronics; [ conducting clinical trials for others; scientific consulting in the field of medical research and medical technology; supply of information in the area of laboratory technology; medical laboratory services; ] provision of scientific information via Internet portals in the field of medical research and biotechnology

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 6, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGALVANI BIOELECTRONICS LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type05 - Joint Venture
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Thursday, March 2, 2017NEW APPLICATION ENTERED
Monday, March 6, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 4, 2017ASSIGNED TO EXAMINER
Friday, May 5, 2017EXAMINERS AMENDMENT -WRITTEN
Friday, May 5, 2017EXAMINERS AMENDMENT E-MAILED
Friday, May 5, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 5, 2017ASSIGNED TO LIE
Friday, May 5, 2017EXAMINER'S AMENDMENT ENTERED
Monday, May 8, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 10, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 24, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 13, 2017PUBLISHED FOR OPPOSITION
Tuesday, June 13, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 29, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, April 18, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 15, 2018CORRECTION UNDER SECTION 7 - PROCESSED
Wednesday, December 4, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 4, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 29, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, September 23, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 23, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 23, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 23, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, September 23, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 23, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 16, 2023TEAS SECTION 8 RECEIVED
Tuesday, November 28, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, November 28, 2023POST REGISTRATION ACTION MAILED - SEC. 8
Wednesday, November 29, 2023TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Thursday, November 30, 2023NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Friday, May 24, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 24, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 24, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 24, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 24, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 30, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED